Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab
Systemic reactions (SR) to venom immunotherapy (VIT) are rare but may occur, with a rate significantly higher for honeybee than for vespid VIT. In patients with repeated SRs to VIT it is difficult to reach the...
Source: Clinical and Molecular Allergy - Category: Allergy & Immunology Authors: Elisa Boni, Cristoforo Incorvaia and Marina Mauro Source Type: research
More News: Allergy & Immunology